ATARA Biotherapeutics (ATRA) Says Agreement Reached with FDA on Design of Phase 3 Trials for ATA 129
Tweet Send to a Friend
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) reached agreement with the U.S. Food and Drug Administration (FDA) on the designs of two ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
